Skip to main content

Month: August 2020

BioXcel Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update

SERENITY I & II Phase 3 trials of BXCL501 achieved all primary and secondary endpoints; New Drug Application (“NDA”) submission to U.S. Food and Drug Administration (“FDA”) planned for Q1 2021Initiating the third dose cohort, 90 mcg, of the TRANQUILITY trial in elderly dementia patientsInitiated a separate efficacy cohort in the Phase 2 trial of BXCL701 in combination with pembrolizumab (“KEYTRUDA®”) to include patients with castrate-resistant prostate cancer (“CRPC”)Strengthened balance sheet through follow-on offering raising approximately $200 million in gross proceedsCompany to host conference call today at 8:30 a.m. ETNEW HAVEN, Conn., Aug. 14, 2020 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify...

Continue reading

Apollo Infrastructure Funds Announce Strategic Investment in US Offshore Wind Developer US Wind Inc.

NEW YORK, Aug. 14, 2020 (GLOBE NEWSWIRE) — Apollo Global Management, Inc. (NYSE: APO) (together with its consolidated subsidiaries, “Apollo” or the “Firm”) today announced that certain funds managed by its affiliates (“Apollo Funds”) have made a structured investment in US Wind Inc. (“US Wind”), an offshore wind energy development company. Apollo Funds have committed to invest through convertible debt and equity up to $265 million to acquire an equity stake in US Wind and fund development and construction costs associated with a major offshore wind energy project off the coast of Maryland.Baltimore, Maryland-based US Wind controls the Maryland Wind Energy Area under a Bureau of Ocean Energy Management (“BOEM”) lease of approximately 80,000 acres located ten to thirty miles off the state’s coast, an area that is sufficient to install...

Continue reading

INNSUITES HOSPITALITY TRUST (IHT) – IHT Continuing Operating Results Improve

Phoenix, AZ, Aug. 14, 2020 (GLOBE NEWSWIRE) — InnSuites Hospitality Trust (NYSE American: IHT) InnSuites Hospitality Trust (IHT) reported total revenues of $6.57 million from continuing operations for the fiscal year ended January 31, 2020 (FY 2020) compared to total revenues from continuing operations of $6.17 million for the fiscal year ended January 31, 2019 (FY2019), an increase of $0.4 million, or 6.5%.Consolidated Net Loss for FY2020 was approximately $2.0 million compared to Consolidated Net Income of $11.1 million for FY2019. Fiscal year ended January 31, 2019 included net income from discontinued operations of $13.1 million as a result of the profitable sales of our Yuma hotel property and our IBC technology subsidiary. We did not sell any of our properties during the fiscal year ended January 31, 2020.FY 2020 consolidated...

Continue reading

Marathon Patent Group Announces $23 Million Contract with Bitmain to Purchase 10,500 S-19 Pro Miners

LAS VEGAS, Aug. 14, 2020 (GLOBE NEWSWIRE) — Marathon Patent Group, Inc. (NASDAQ:MARA) (“Marathon” or “Company”), a Nasdaq-listed cryptocurrency mining company, today announced that it has entered into a Long Term Purchase Contract with Bitmain for the purchase of 10,500 next generation Antminer S-19 Pro ASIC Miners.Marathon’s Chief Executive Officer, Merrick Okamoto, stated, “The execution of this contract with Bitmain represents a milestone event for our company. This investment is expected to result in Marathon being one of, if not the largest, Bitcoin miner in North America.”Okamoto continued, “Today’s news comes on the heels of recent incremental business growth through the purchase of what now is expected to total 13,520 next generation miners generating 1.55 Exahash upon full installation. I would like...

Continue reading

TLC Submits Investigational New Drug (IND) Application for TLC19 Inhalable Liposomal Hydroxychloroquine for COVID-19

1% of oral dose for 30-fold lung exposure and reduced cardiotoxicityA cost-effective, easily accessible, user-friendly potential treatment/prevention optionSOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Aug. 14, 2020 (GLOBE NEWSWIRE) — TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced the submission of an Investigational New Drug (IND) Application to the Taiwan Food and Drug Administration (TFDA) for TLC19 Hydroxychloroquine Liposome Inhalation Suspension for the treatment of coronavirus disease 2019 (COVID-19).Is hydroxychloroquine (HCQ) still a viable drug in the prevention and treatment of COVID-19? Studies by X. Yao et al and S. Perinel et al suggest that HCQ can prevent the acidification of intracellular organelles,...

Continue reading

Crawford United Corporation Announces Second Quarter 2020 Results

CLEVELAND, Ohio, Aug. 14, 2020 (GLOBE NEWSWIRE) — Crawford United Corporation (OTC: CRAWA), a growth-oriented holding company serving diverse markets, today reported results for the three-month and six-month periods ended June 30, 2020.For the quarter, sales were $18.6 million compared to $24.5 million in the same period last year, a decrease of 24%.  In this quarter, the Company recorded operating income of $0.5 million compared to operating income of $2.8 million in the same period last year.  Net income was $0.2 million, or $0.07 per fully diluted share, compared to $1.8 million, or $0.57 per fully diluted share in the same period last year.For the six months ended June 30, 2020, sales were $43.9 million compared to $46.4 million in the same period last year, a decrease of 5%.  In this six-month period, the Company recorded operating...

Continue reading

Power Solutions International Announces Second Quarter and First Half 2020 Financial Results

WOOD DALE, Ill., Aug. 14, 2020 (GLOBE NEWSWIRE) — Power Solutions International, Inc. (“the Company”) (OTC Pink:  PSIX), a leader in the design, engineering and manufacture of emission-certified engines and power systems, announced second quarter and first half 2020 financial results.Second Quarter 2020 ResultsThe novel coronavirus COVID-19 pandemic (“COVID-19 pandemic”) has resulted in the implementation of significant governmental measures to control the spread of the virus, including quarantines, travel restrictions, business shutdowns and restrictions on the movement of people in the United States and abroad, and the related recent historic decline in oil demand. The Company has experienced a significant overall reduction in demand for its products which is, in large part, attributable to the impact of the COVID-19 pandemic. ...

Continue reading

Hooker Furniture to Host Second Quarter Earnings Call September 3

MARTINSVILLE, Va., Aug. 14, 2020 (GLOBE NEWSWIRE) — Hooker Furniture Corporation (Nasdaq-GS:HOFT) will present its fiscal 2021 second quarter financial results via teleconference and live internet web cast on Thursday morning, September 3, 2020 at 9:00 AM Eastern Time. The dial-in number for domestic callers is 877.665.2466 and the number for international callers is 678.894.3031. The conference ID number is 6511379.Hooker’s fiscal 2021 second quarter began on May 4, 2020 and ended on August 2, 2020.The call will be simultaneously web cast and archived for replay on the Company’s web site at hookerfurniture.com in the Company section under Investor Relations.Hooker Furniture Corporation, in its 97th year of business, is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.